TY  - GEN
AU  - Sun,Dian-Min
AU  - Tang,Bu-Fu
AU  - Li,Zhen-Xiang
AU  - Guo,Hong-Bo
AU  - Cheng,Jin-Ling
AU  - Song,Ping-Ping
AU  - Zhao,Xin
TI  - MiR-29c reduces the cisplatin resistance of non-small cell lung cancer cells by negatively regulating the PI3K/Akt pathway
SN  - 2045-2322
PY  - 2019///1022
KW  - A549 Cells
KW  - Adult
KW  - Animals
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Case-Control Studies
KW  - Cisplatin
KW  - therapeutic use
KW  - Down-Regulation
KW  - genetics
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Gene Expression Regulation, Neoplastic
KW  - Genes, Tumor Suppressor
KW  - physiology
KW  - Humans
KW  - Lung Neoplasms
KW  - Male
KW  - Mice
KW  - Mice, Nude
KW  - MicroRNAs
KW  - Phosphatidylinositol 3-Kinases
KW  - Proto-Oncogene Proteins c-akt
KW  - Signal Transduction
KW  - Tumor Cells, Cultured
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/s41598-018-26381-w
ER  -